# Fatty Acid Supplementation in Children With ASD

> **NCT03550209** · PHASE2 · COMPLETED · sponsor: **Sarah Keim** · enrollment: 72 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** LCPUFA Oil Supplement
- **DIETARY_SUPPLEMENT:** Canola Oil Placebo

## Key facts

- **NCT ID:** NCT03550209
- **Lead sponsor:** Sarah Keim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-28
- **Primary completion:** 2020-01-10
- **Final completion:** 2020-01-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2021-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03550209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03550209, "Fatty Acid Supplementation in Children With ASD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03550209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*